Screening and risk analysis of atrial fibrillation after radiotherapy for breast cancer: Rationale and design for the Watch Your HeaRT cohort study (WATCH)
Author:
Saint-Lary Laura1, Pinel Baptiste2, Panh Loïc3, Jimenez Gaëlle2, Geffrelot Julien4, Kirova Youlia5, Camilleri Jérémy2, Broggio David6, Bernier Marie-Odile1, Mandin Corinne1, Levy Christelle4, Boveda Serge3, Thariat Juliette4, Jacob Sophie1
Affiliation:
1. Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SESANE/LEPID 2. Department of Radiation Oncology (ORION), Clinique Pasteur 3. Department Heart Rhythm Management, Cardiology, Clinique Pasteur 4. Department of Radiation Oncology, Centre François Baclesse 5. Department of Radiation Oncology, Institut Curie 6. Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SDOS/LEDI
Abstract
Abstract
Background
Post-radiotherapy atrial fibrillation (AF) in breast cancer (BC) patients is a relatively new and understudied topic. AF can increase the risk of stroke and other serious cardiovascular complications, compromising patients' quality of life and survival. Detection of AF, both asymptomatic and symptomatic forms, is therefore essential for optimal management. The objective of the WATCH study is to assess the incidence of AF (symptomatic or asymptomatic) occurring throughout a 5-years follow-up after RT and to investigate whether cardiac radiation exposure is associated with the occurrence of such events.
Methods
WATCH is a cohort study that will include 200 patients over 65 years old, treated with radiotherapy for BC five years before inclusion, without history of AF. Cross-sectional screening for AF at the time of the scheduled five-year post-radiotherapy visit is conducted by recording data from a Withings ScanWatch smartwatch for one month, confirmed by an ECG, and validated by a physician. In addition, a transthoracic echocardiography is performed, providing comprehensive assessment of cardiac structures, and allowing to investigate underlying etiology and assess the risk of complications. Patient's medical record provides retrospective information on the timing and risk factors for the occurrence of AF and other arrhythmias and cardiac diseases during the 5 years following RT. The development of deep learning algorithms for auto-segmentation analysis of potentially critical sub-structures for the occurrence of AF, including cardiac chambers, sinoatrial node, atrioventricular node, coronary arteries, pulmonary veins, will produce dosimetry linked to previous radiotherapy treatment for all contoured structures. The inclusions started in October 2023 and will continue until mid-2026 to include 200 patients. The results are expected by the end of 2026.
Discussion
This study will contribute to generating new knowledge on AF after radiotherapy for BC, and help considering AF screening into routine clinical practice in these patients. Identifying the dose-risk associations would improve RT delivery protocols to limit the occurrence of these arrhythmias and, if necessary, initiate appropriate treatment.
Trial registration
ClinicalTrials.gov:NCT06073509. Registration date: 10/09/2023
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Sung H, Rl JF et al. S, M L, I S, A J, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin [Internet]. mai. 2021 [cité 19 juin 2024];71(3). Disponible sur: https://pubmed.ncbi.nlm.nih.gov/33538338/ 2. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). The Lancet. 14 mars. 2015;385(9972):977–1010. 3. Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification;Bergom C;JACC CardioOncology sept,2021 4. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 14 mars. 2013;368(11):987–98. 5. Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures;Bogaard VAB;J Clin Oncol Off J Am Soc Clin Oncol 10 avr,2017
|
|